Monogram Orthopaedics, Inc. (MGRM) Research

Monogram Orthopaedics, Inc. (MGRM) specializes in developing technologies that enable the mass personalization and optimization of orthopedic implants. The company's strategy involves producing and marketing a comprehensive array of tools for reconstructive joint replacement surgeries, including advanced robotic surgical equipment with integrated software, specialized orthopedic implants, tissue ablation instruments, navigation consumables, and other related surgical accessories. Demonstrating its capabilities, a prototype robot precisely places optimized implants into synthetic bone specimens by executing carefully planned surgical pathways. The company was founded in 2016 and was initially known as Monogram Arthroplasty Inc. before officially rebranding to Monogram Orthopaedics, Inc. in March 2017. Its corporate headquarters are located in Austin, Texas.

Market snapshot

Symbol
MGRM
Price
$6.00
Day change
-1.80%
Market cap
$243.8M
P/E ratio
-16.54x
52-week range
1.918-6.425
Sector
Healthcare
Industry
Medical - Devices
Analyst price target
$5.40

Peer companies

  • BioSig Technologies, Inc. (BSGM)
  • Second Sight Medical Products Inc (EYESW)
  • Inozyme Pharma, Inc. (INZY)
  • Lifecore Biomedical, Inc. (LFCR)
  • Nevro Corp. (NVRO)
  • Shineco, Inc. (SISI)
  • Acelyrin, Inc. (SLRN)
  • Sonida Senior Living, Inc. (SNDA)

Recent insider activity

  • Gray Colleen — D-Return (8000 shares) on 2025-10-07
  • Gray Colleen — A-Award (5000 shares) on 2025-01-08
  • Gray Colleen — trade (3000 shares) on 2030-11-30
  • Van Kirk Richard Lee Jr — D-Return (7000 shares) on 2025-10-07
  • Unis Douglas — D-Return (1475000 shares) on 2025-10-07

Open Monogram Orthopaedics, Inc. (MGRM) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.